2024 Q2 Form 10-Q Financial Statement

#000156168024000054 Filed on April 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.155B $939.4M
YoY Change 37.93% 20.49%
Cost Of Revenue $881.2M $713.1M
YoY Change 33.64% 20.81%
Gross Profit $273.7M $226.3M
YoY Change 53.82% 19.48%
Gross Profit Margin 23.7% 24.09%
Selling, General & Admin $124.6M $102.3M
YoY Change 26.77% 15.97%
% of Gross Profit 45.5% 45.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.697M $7.327M
YoY Change 25.6% 3.87%
% of Gross Profit 2.81% 3.24%
Operating Expenses $124.6M $111.0M
YoY Change 17.89% 25.86%
Operating Profit $149.2M $115.3M
YoY Change 106.33% 24.87%
Interest Expense $0.00 $57.00K
YoY Change
% of Operating Profit 0.0% 0.05%
Other Income/Expense, Net $9.934M $15.23M
YoY Change -10.45% 100.24%
Pretax Income $159.2M $130.6M
YoY Change 90.82% 26.52%
Income Tax $41.20M $31.58M
% Of Pretax Income 25.87% 24.19%
Net Earnings $118.0M $99.06M
YoY Change 94.33% 32.53%
Net Earnings / Revenue 10.22% 10.54%
Basic Earnings Per Share $1.25 $1.04
Diluted Earnings Per Share $1.25 $1.03
COMMON SHARES
Basic Shares Outstanding 94.88M shares 95.43M shares
Diluted Shares Outstanding 94.74M shares 95.85M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $492.9M $944.0M
YoY Change -49.78% -2.31%
Cash & Equivalents $492.9M $944.0M
Short-Term Investments
Other Short-Term Assets $10.03M
YoY Change -44.15%
Inventory $3.466B $3.423B
Prepaid Expenses
Receivables $45.63M $59.12M
Other Receivables $66.01M $66.01M
Total Short-Term Assets $4.070B $4.502B
YoY Change -5.44% 5.94%
LONG-TERM ASSETS
Property, Plant & Equipment $63.42M $65.90M
YoY Change -5.05% -1.46%
Goodwill $139.3M $139.3M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $133.6M $124.7M
YoY Change -4.55% -6.97%
Other Assets $51.35M $42.71M
YoY Change 26.34% 22.56%
Total Long-Term Assets $525.8M $467.9M
YoY Change 10.51% -4.4%
TOTAL ASSETS
Total Short-Term Assets $4.070B $4.502B
Total Long-Term Assets $525.8M $467.9M
Total Assets $4.596B $4.970B
YoY Change -3.86% 4.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.41M $51.74M
YoY Change -26.76% -10.09%
Accrued Expenses $370.3M $360.9M
YoY Change 20.54% -17.27%
Deferred Revenue $58.41M $51.16M
YoY Change 25.04% 17.77%
Short-Term Debt $32.10M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $486.2M $518.5M
YoY Change -1.07% 5.0%
LONG-TERM LIABILITIES
Long-Term Debt $962.1M $1.384B
YoY Change -30.28% 0.33%
Other Long-Term Liabilities $8.497M $18.26M
YoY Change -32.07% 42.82%
Total Long-Term Liabilities $970.6M $1.402B
YoY Change -30.29% 1.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $486.2M $518.5M
Total Long-Term Liabilities $970.6M $1.402B
Total Liabilities $1.457B $1.920B
YoY Change -22.67% 2.54%
SHAREHOLDERS EQUITY
Retained Earnings $3.139B $3.049B
YoY Change 8.41% 6.5%
Common Stock $939.0K $949.0K
YoY Change -5.25% -5.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.139B $3.050B
YoY Change
Total Liabilities & Shareholders Equity $4.596B $4.970B
YoY Change -3.86% 4.87%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $118.0M $99.06M
YoY Change 94.33% 32.53%
Depreciation, Depletion And Amortization $7.697M $7.327M
YoY Change 25.6% 3.87%
Cash From Operating Activities $23.15M $144.7M
YoY Change -62.72% 6.71%
INVESTING ACTIVITIES
Capital Expenditures $6.130M $6.417M
YoY Change 3.13% -1.29%
Acquisitions
YoY Change
Other Investing Activities -$9.017M $6.154M
YoY Change 67.23% -308.54%
Cash From Investing Activities -$15.15M -$263.0K
YoY Change 33.62% -97.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -459.1M -69.44M
YoY Change 1193.49% 40.12%
NET CHANGE
Cash From Operating Activities 23.15M 144.7M
Cash From Investing Activities -15.15M -263.0K
Cash From Financing Activities -459.1M -69.44M
Net Change In Cash -451.1M 75.05M
YoY Change -3054.08% -2.07%
FREE CASH FLOW
Cash From Operating Activities $23.15M $144.7M
Capital Expenditures $6.130M $6.417M
Free Cash Flow $17.02M $138.3M
YoY Change -69.69% 7.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
156603000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
37996000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
37996000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
158639000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
157093000 usd
CY2024Q1 us-gaap Senior Notes
SeniorNotes
1095192000 usd
CY2023Q4 us-gaap Senior Notes
SeniorNotes
1094249000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1920317000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1900950000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
94877377 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94877377 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
949000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
955000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3049646000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3010958000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
12000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
2680000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3049658000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3013638000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4969975000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4914588000 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
288337000 usd
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
0 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
0 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3048697000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3010003000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssets
CY2024Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2023Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
156603000 usd
CY2024Q1 us-gaap Assets
Assets
4969975000 usd
CY2023Q4 us-gaap Assets
Assets
4914588000 usd
CY2024Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
51736000 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
64833000 usd
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
485052000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
453531000 usd
CY2024Q1 us-gaap Loans Payable
LoansPayable
288337000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
95530512 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
95530512 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
130580000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
103207000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31584000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27350000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
98996000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
75857000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-59000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1115000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
99055000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
74742000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95232315 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101019253 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95846756 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101706438 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3013638000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
98996000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1041000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
16572000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6679000 usd
CY2024Q1 tph Stock Repurchased During Period Including Shares Withheld For Taxes Value
StockRepurchasedDuringPeriodIncludingSharesWithheldForTaxesValue
50247000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2609000 usd
CY2024Q1 tph Adjustment To Paid In Capital Acquisition Of Joint Venture Minority Interest
AdjustmentToPaidInCapitalAcquisitionOfJointVentureMinorityInterest
1268000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3049658000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2836531000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
75857000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
232000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9780000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3861000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
37821000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2395000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2866485000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
98996000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
75857000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7327000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7054000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
57000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
227000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6679000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3861000 usd
CY2024Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
402000 usd
CY2023Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
717000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-3495000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
84500000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-31965000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-99503000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-28373000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5809000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
429000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13097000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4780000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
31805000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6752000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
144744000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
135639000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6417000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6501000 usd
CY2024Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-717000 usd
CY2023Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0 usd
CY2024Q1 us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
8213000 usd
CY2023Q1 us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
2951000 usd
CY2024Q1 tph Distributions From Unconsolidated Entities
DistributionsFromUnconsolidatedEntities
13650000 usd
CY2023Q1 tph Distributions From Unconsolidated Entities
DistributionsFromUnconsolidatedEntities
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-263000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9452000 usd
CY2024Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
3877000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
2395000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1041000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
232000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16572000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9780000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50028000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
37610000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-69436000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-49553000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
75045000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
76634000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
868953000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
889664000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
943998000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
966298000 usd
CY2024Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
10 state
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements requires our management to make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosures of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from our estimates.</span></div>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents and Concentration of Credit Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define cash and cash equivalents as cash on hand, demand deposits with financial institutions, and short-term liquid investments with a maturity date of less than three months from the date of acquisition, including U.S. Treasury bills and government money-mark funds with maturities of 90 days or less when purchased. The Company’s cash balances exceed federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.</span></div>
CY2024Q1 tph Number Of Principal Businesses
NumberOfPrincipalBusinesses
2 business_line
CY2024Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
3 subsegment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
939402000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
779661000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
130580000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
103207000 usd
CY2024Q1 us-gaap Assets
Assets
4969975000 usd
CY2023Q4 us-gaap Assets
Assets
4914588000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
99055000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
99055000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
74742000 usd
CY2023Q4 tph Real Estate Inventories Owned Model Homes
RealEstateInventoriesOwnedModelHomes
306565000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
74742000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95232315 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101019253 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
614441 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
687185 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95846756 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101706438 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2510864 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2671754 shares
CY2024Q1 tph Escrow Proceeds And Other Accounts Receivable Net
EscrowProceedsAndOtherAccountsReceivableNet
59120000 usd
CY2023Q4 tph Escrow Proceeds And Other Accounts Receivable Net
EscrowProceedsAndOtherAccountsReceivableNet
158622000 usd
CY2024Q1 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
66013000 usd
CY2023Q4 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
66014000 usd
CY2024Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
125133000 usd
CY2023Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
224636000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
436000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
436000 usd
CY2024Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1526569000 usd
CY2023Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1402762000 usd
CY2024Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1255357000 usd
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1299074000 usd
CY2024Q1 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
154279000 usd
CY2023Q4 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
153615000 usd
CY2024Q1 tph Real Estate Inventories Owned Model Homes
RealEstateInventoriesOwnedModelHomes
308721000 usd
CY2024Q1 tph Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Inventory Real Estate Owned
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInventoryRealEstateOwned
3244926000 usd
CY2023Q4 tph Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Inventory Real Estate Owned
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInventoryRealEstateOwned
3162016000 usd
CY2024Q1 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
177957000 usd
CY2023Q4 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
175467000 usd
CY2024Q1 tph Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Real Estate Not Owned
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRealEstateNotOwned
177957000 usd
CY2023Q4 tph Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Real Estate Not Owned
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRealEstateNotOwned
175467000 usd
CY2024Q1 us-gaap Inventory Real Estate
InventoryRealEstate
3422883000 usd
CY2023Q4 us-gaap Inventory Real Estate
InventoryRealEstate
3337483000 usd
CY2024Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
36156000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
37479000 usd
CY2024Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
36156000 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
37479000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
221647000 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
191411000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
36156000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
37479000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
30846000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
20251000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
226957000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
208639000 usd
CY2024Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2024Q1 tph Land Option Abandonments And Pre Acquisition Charges
LandOptionAbandonmentsAndPreAcquisitionCharges
402000 usd
CY2023Q1 tph Land Option Abandonments And Pre Acquisition Charges
LandOptionAbandonmentsAndPreAcquisitionCharges
717000 usd
CY2024Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
402000 usd
CY2023Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
717000 usd
CY2024Q1 tph Variable Interest Entity Deposits At Risk
VariableInterestEntityDepositsAtRisk
177957000 usd
CY2024Q1 tph Variable Interest Entity Remaining Purchase Price
VariableInterestEntityRemainingPurchasePrice
1510818000 usd
CY2024Q1 tph Variable Interest Entity Consolidated Inventory Held
VariableInterestEntityConsolidatedInventoryHeld
0 usd
CY2023Q4 tph Variable Interest Entity Deposits At Risk
VariableInterestEntityDepositsAtRisk
175467000 usd
CY2023Q4 tph Variable Interest Entity Remaining Purchase Price
VariableInterestEntityRemainingPurchasePrice
1206798000 usd
CY2023Q4 tph Variable Interest Entity Consolidated Inventory Held
VariableInterestEntityConsolidatedInventoryHeld
0 usd
CY2024Q1 us-gaap Goodwill
Goodwill
139300000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
139300000 usd
CY2024Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
10030000 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
8462000 usd
CY2024Q1 us-gaap Deposit Assets
DepositAssets
7726000 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
8726000 usd
CY2024Q1 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
1192000 usd
CY2023Q4 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
1192000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4716000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5089000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65338000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66284000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
65904000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
66404000 usd
CY2024Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
3733000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
936000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
158639000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
157093000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
24081000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
68575000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
106602000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
106993000 usd
CY2024Q1 tph Estimated Cost For Completion Of Real Estate Inventories
EstimatedCostForCompletionOfRealEstateInventories
124550000 usd
CY2023Q4 tph Estimated Cost For Completion Of Real Estate Inventories
EstimatedCostForCompletionOfRealEstateInventories
108175000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
51160000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43991000 usd
CY2024Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
54705000 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
23138000 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
24191000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
8470000 usd
CY2024Q1 tph Other Tax Liability
OtherTaxLiability
3451000 usd
CY2023Q4 tph Other Tax Liability
OtherTaxLiability
2976000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
78049000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
78782000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
18263000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
12431000 usd
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
485052000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
453531000 usd
CY2024Q1 us-gaap Loans Payable
LoansPayable
288337000 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
288337000 usd
CY2023Q4 tph Number Of Seller Financed Loan
NumberOfSellerFinancedLoan
2 loan
CY2024Q1 tph Number Of Seller Financed Loan
NumberOfSellerFinancedLoan
2 loan
CY2024Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
36200000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
37500000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1300000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1200000 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
24200000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
8500000 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2023Q4 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
66000000 usd
CY2024Q1 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
66000000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
106993000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
104375000 usd
CY2024Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
7900000 usd
CY2023Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5902000 usd
CY2024Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
8291000 usd
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
8750000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
106602000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
101527000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
2843000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
2835000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1890000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1927000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6679000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3861000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
62500000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2024Q1 tph Increase Decrease In Shares Withheld For Taxes
IncreaseDecreaseInSharesWithheldForTaxes
217000 usd
CY2023Q1 tph Increase Decrease In Shares Withheld For Taxes
IncreaseDecreaseInSharesWithheldForTaxes
211000 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
277000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
259000 usd
CY2024Q1 tph Amortization Of Deferred Loan Costs
AmortizationOfDeferredLoanCosts
1026000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
38000000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
38000000 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3400000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3400000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31600000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27400000 usd
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
CY2024Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
CY2024Q1 tph Interest Paid Capitalized Net
InterestPaidCapitalizedNet
-17024000 usd
CY2023Q1 tph Interest Paid Capitalized Net
InterestPaidCapitalizedNet
-15866000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
329000 usd
CY2023Q1 tph Amortization Of Deferred Loan Costs
AmortizationOfDeferredLoanCosts
986000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001561680-24-000054-index-headers.html Edgar Link pending
0001561680-24-000054-index.html Edgar Link pending
0001561680-24-000054.txt Edgar Link pending
0001561680-24-000054-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q12024tphex311.htm Edgar Link pending
q12024tphex312.htm Edgar Link pending
q12024tphex321.htm Edgar Link pending
q12024tphex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tph-20240331.htm Edgar Link pending
tph-20240331.xsd Edgar Link pending
tph-20240331_g1.jpg Edgar Link pending
tph-20240331_def.xml Edgar Link unprocessable
tph-20240331_lab.xml Edgar Link unprocessable
tph-20240331_pre.xml Edgar Link unprocessable
tph-20240331_htm.xml Edgar Link completed
tph-20240331_cal.xml Edgar Link unprocessable